You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed/refractory B-cell non-Hodgkin lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Scleroderma, Autoimmune Diseases Trial in Hangzhou (Assigned Interventions CD19/BCMA CAR T-cells)

Recruiting
  • Scleroderma
  • Autoimmune Diseases
  • Assigned Interventions CD19/BCMA CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 11, 2021

French National Observatory of Non-small Cell Lung and Molecular

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
    • Agen, France
    • +132 more
    Jun 29, 2022

    Vaso-inotropic Score and ECMO-VA Support in Post-cardiotomy

    Completed
    • EMCO-VA
    • data collection
    • Dijon, France
      Chu Dijon Bourogne
    Jun 7, 2022

    Infertility Trial in Sofia (Intrauterine administration of PBMC immunomodulated with IFNt)

    Recruiting
    • Infertility
    • Intrauterine administration of PBMC immunomodulated with IFNt
    • Sofia, Bulgaria
      Nadezhda Women's Health Hospital
    Mar 7, 2023

    NSCLC Trial in Guangzhou (Almonertinib, chemo)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun yat-sen Univerisity Cancer Center
    Jun 30, 2021

    Stage IA NSCLC, Stage IB NSCLC, Stage IIA NSCLC Trial in Philadelphia (breath test, laboratory biomarker analysis)

    Active, not recruiting
    • Stage IA Non-small Cell Lung Cancer
    • +3 more
    • breath test
    • laboratory biomarker analysis
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Oct 11, 2021

    Refractory Chronic Cough Trial (Nalbuphine Hydrochloride, Placebo)

    Not yet recruiting
    • Refractory Chronic Cough
    • Nalbuphine Hydrochloride
    • Placebo
    • (no location specified)
    Jul 18, 2023

    Relapsed Multiple Myeloma Trial in Italy (Isatuximab-dexamethasone)

    Active, not recruiting
    • Relapsed Multiple Myeloma
    • Ancona, Italy
    • +14 more
    Mar 24, 2022

    Neuroblastoma Trial in San Francisco (124I-Metaiodobenzylguanidine (MIBG) (no-carrier added), 124I-MIBG (carrier added),

    Terminated
    • Neuroblastoma
    • 124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    May 12, 2021

    Severe Combined Immunodeficiency Due to RAG1 Deficiency Trial in Leiden (Gene therapy)

    Recruiting
    • Severe Combined Immunodeficiency Due to RAG1 Deficiency
    • Gene therapy
    • Leiden, Netherlands
      Leiden University Medical Center
    Dec 3, 2021

    Neuropathic Pain Trial in Lausanne (Hypnosis, Open label )

    Recruiting
    • Neuropathic Pain
    • Hypnosis
    • Open label placebo
    • Lausanne, Switzerland
      Lausanne University Hospital (CHUV)
    Jun 28, 2022

    BAFF Levels and Lupus Nephritis (LN)

    Not yet recruiting
    • Lupus Nephritis
    • BAFF serum levels
    • (no location specified)
    Apr 30, 2020

    Viral Respiratory Tract Infection Trial in London (Neumifil, Placebo)

    Completed
    • Viral Respiratory Tract Infection
    • London, United Kingdom
      Hammersmith Medicines Research (HMR)
    Jul 25, 2022

    NSCLC Trial in Tianjin (biological, drug, radiation)

    Recruiting
    • Non-small Cell Lung Cancer
    • Camrelizumab
    • +5 more
    • Tianjin, China
      Liu ningbo
    May 7, 2021

    Frailty Trial in Chapel Hill (Pragmatic, exploratory study of Precision Medicine)

    Enrolling by invitation
    • Frailty
    • Pragmatic, exploratory study of Precision Medicine
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Jan 11, 2023

    COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

    Active, not recruiting
    • COVID-19
    • LYB002V14
    • +2 more
    • Chengdu, Sichuan, China
      Affiliated Hospital of North Sichuan MedicalCollege
    Jun 29, 2023

    Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

    Not yet recruiting
    • Chronic Hepatitis B
    • PEG IFN α-2b; TAF
    • (no location specified)
    Aug 5, 2022

    Carcinoma, Small Cell Trial in Japan

    Active, not recruiting
    • Carcinoma, Small Cell
      • Aichi, Japan
      • +29 more
      Dec 6, 2022

      Ischemic Heart Disease, Myocardial Infarction, Inflammation Trial in Cambridge (RiTUXimab Injection)

      Completed
      • Ischemic Heart Disease
      • +2 more
      • RiTUXimab Injection
      • Cambridge, Cambridgeshire, United Kingdom
        Papworth Hospital NHS Trust
      Sep 13, 2021

      Ovarian Tumors Trial in Canada, Spain, United States (Niraparib, TSR-042, Bevacizumab)

      Recruiting
      • Ovarian Neoplasms
      • Birmingham, Alabama
      • +24 more
      Dec 9, 2022

      Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)

      Completed
      • Psoriasis Vulgaris
      • UVB Phototherapy Burn
      • Serum Interleukin 17 levels
      • NB-UVB
      • Qinā, Qena, Egypt
        South Valley University
      Dec 9, 2022

      Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

      Active, not recruiting
      • Neoplasms
      • Letetresgene autoleucel (lete-cel, GSK3377794)
      • +2 more
      • Duarte, California
      • +36 more
      Oct 28, 2022

      Advanced or Inoperable Gastric Cancer Trial in Worldwide (pamiparib, Placebo)

      Completed
      • Advanced or Inoperable Gastric Cancer
      • Santa Rosa, California
      • +140 more
      Jan 10, 2023

      NAFLD, Obesity, Type 2 Diabetes Trial (Saroglitazar)

      Not yet recruiting
      • NAFLD
      • +4 more
      • (no location specified)
      May 25, 2023

      Miscarriage, Recurrent Trial in Kuala Lumpur (GNRH Analoge, Duphaston, Letrozole)

      Completed
      • Miscarriage, Recurrent
      • GNRH Analoge, Duphaston, Letrozole
      • Kuala Lumpur, Malaysia
        UniversitiKMMC
      Jun 24, 2022